James B Weissman insider trades: Dicerna Pharmaceuticals (DRNA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 6, 2021 | DRNA | ↓ Sell | 30,000 | $39.09 | $1.2M | Direct | Jul 8, 2021 (2d) |
| Apr 16, 2021 | DRNA | ↓ Sell | 4,904 | $29.99 | $147K | Direct | Apr 20, 2021 (4d) |
| Feb 5, 2021 | DRNA | ↓ Sell | 7,156 | $26.99 | $193K | Direct | Feb 8, 2021 (3d) |
| Jan 12, 2021 | DRNA | ↓ Sell | 5,808 | $24.08 | $140K | Direct | Jan 13, 2021 (1d) |
| Jan 11, 2021 | DRNA | ↓ Sell | 3,800 | $23.99 | $91K | Direct | Jan 12, 2021 (1d) |
| Dec 1, 2020 | DRNA | ↓ Sell | 4,360 | $25.21 | $110K | Direct | Dec 3, 2020 (2d) |
| Nov 2, 2020 | DRNA | ↓ Sell | 4,360 | $20.95 | $91K | Direct | Nov 3, 2020 (1d) |
| Oct 15, 2020 | DRNA | ↓ Sell | 8,720 | $20.20 | $176K | Direct | Oct 19, 2020 (4d) |
| Aug 3, 2020 | DRNA | ↓ Sell | 4,360 | $22.47 | $98K | Direct | Aug 5, 2020 (2d) |
| Jul 1, 2020 | DRNA | ↓ Sell | 4,360 | $26.53 | $116K | Direct | Jul 6, 2020 (5d) |
| Jun 1, 2020 | DRNA | ↓ Sell | 4,360 | $21.06 | $92K | Direct | Jun 2, 2020 (1d) |
| May 4, 2020 | DRNA | ↓ Sell | 4,360 | $20.20 | $88K | Direct | May 6, 2020 (2d) |
| Apr 13, 2020 | DRNA | ↓ Sell | 4,360 | $20.20 | $88K | Direct | Apr 14, 2020 (1d) |
| Mar 2, 2020 | DRNA | ↓ Sell | 4,360 | $20.61 | $90K | Direct | Mar 3, 2020 (1d) |
| Feb 3, 2020 | DRNA | ↓ Sell | 4,360 | $20.20 | $88K | Direct | Feb 4, 2020 (1d) |
| Jan 2, 2020 | DRNA | ↓ Sell | 4,360 | $21.88 | $95K | Direct | Jan 3, 2020 (1d) |
| Dec 2, 2019 | DRNA | ↓ Sell | 20,000 | $26.00 | $520K | Direct | Dec 3, 2019 (1d) |
| Nov 19, 2019 | DRNA | ↓ Sell | 40,000 | $23.00 | $920K | Direct | Nov 20, 2019 (1d) |
| Nov 14, 2019 | DRNA | ↓ Sell | 20,000 | $20.00 | $400K | Direct | Nov 15, 2019 (1d) |
| Oct 31, 2019 | DRNA | ↓ Sell | 15,000 | $18.00 | $270K | Direct | Nov 1, 2019 (1d) |
| Aug 23, 2019 | DRNA | ↓ Sell | 14,680 | $13.07 | $192K | Direct | Aug 23, 2019 (0d) |
| Apr 2, 2019 | DRNA | ↓ Sell | 15,000 | $15.00 | $225K | Direct | Apr 4, 2019 (2d) |
| Sep 5, 2018 | DRNA | ↓ Sell | 2,301 | $17.50 | $40K | Direct | Sep 6, 2018 (1d) |
| May 9, 2018 | DRNA | ↓ Sell | 10,000 | $15.00 | $150K | Direct | May 11, 2018 (2d) |
| Apr 20, 2018 | DRNA | ↓ Sell | 8,965 | $13.00 | $117K | Direct | Apr 24, 2018 (4d) |
| Mar 19, 2018 | DRNA | ↓ Sell | 1,035 | $13.00 | $13K | Direct | Mar 21, 2018 (2d) |
| May 12, 2016 | DRNA | ↑ Buy | 5,000 | $3.29 | $16K | Direct | May 16, 2016 (4d) |
| Jan 29, 2014 | DRNA | ↑ Buy | 1,000 | $15.00 | $15K | Direct | Feb 20, 2014 (22d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James B Weissman's insider trades
James B Weissman is Chief Operating Officer & EVP at Dicerna Pharmaceuticals (DRNA). Since Jan 29, 2014, James has reported 2 open-market purchases worth $31K and 26 sales worth $5.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (26 filings), grants and awards (10 filings), shares withheld for taxes (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.